It is not bouncing too well from 24, and I fear that with uncertainties about imaging reimbursments, they may have a tough year. I am staying away for now. IMGC.
Looks as if our avoidance of IMGC was correct, it seems now that it has closed the gap a tad under $22, the question does the old support just above $21 hold, or do we go and retest yearly lows. Right now, I am staying on the sideline with IMGC.